EHR algorithm can be used to detect, classify diabetes

EHR algorithm can be used to detect, classify diabetes
Data from electronic health records can be used to detect more cases of diabetes than claim codes alone and can be used to accurately distinguish between type 1 and type 2 diabetes, according to a study published online Nov. 27 in Diabetes Care.

(HealthDay)—Data from electronic health records (EHRs) can be used to detect more cases of diabetes than claim codes alone and can be used to accurately distinguish between type 1 and type 2 diabetes, according to a study published online Nov. 27 in Diabetes Care.

To classify type 1 versus type 2 disease, Michael Klompas, M.D., M.P.H., of Harvard Medical School and the Harvard Pilgrim Health Care Institute in Boston, and colleagues used four years of structured EHR data, such as laboratory test results, diagnosis codes, and suggestive prescriptions, from a large, multispecialty ambulatory practice serving approximately 700,000 patients. The optimized algorithm was tested in a cohort of 210 patients and validated in an additional cohort.

The researchers found that the algorithm flagged 43,177 patients. For type 1 diabetes, the sensitivity and of the International Classification of Diseases version 9 codes were 26 and 94 percent, respectively, for type 1 codes alone, and 90 and 57 percent, respectively, for two or more type 1 codes and any number of type 2 codes. Using an optimized algorithm incorporating the ratio of these codes plus additional information on plasma C-peptide and autoantibody levels and suggestive prescriptions, 100 percent of patients with type 1 diabetes were flagged. On validation, the optimized algorithm correctly identified 35 of 36 patients with .

"In sum, we demonstrate the utility of EHR-based algorithms to detect and classify patients with diabetes," the authors write.

One author is an employee of Heliotropic Inc.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Cataract risk up for statin users with type 2 diabetes

date Aug 13, 2012

(HealthDay) -- Statin use, which is substantially higher in patients with type 2 diabetes, correlates with an increased risk of age-related (AR) cataracts, according to a study published in the August issue ...

Lung cancer risk unaffected by metformin use in diabetes

date Aug 30, 2012

(HealthDay)—Patients with type 2 diabetes who take metformin do not have a reduced risk of lung cancer, in contrast to previous observational studies, according to a study published online Aug. 24 in Diabetes Care.

Recommended for you

Neighborhood environments and risk for type 2 diabetes

date 14 hours ago

Neighborhood resources to support greater physical activity and, to a lesser extent, healthy diets appear to be associated with a lower incidence of type 2 diabetes, although the results vary by the method ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.